CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 45 enrolled
Drug / intervention
alkaline water +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01487954
NCT01487954Phase 2Completed
CompareCT.gov

Alkaline Water Consumption to Reduce Skin Radiation Toxicity in Women With Breast Cancer

Case Comprehensive Cancer Center·interventional·Posted Dec 8, 2011·Updated Jun 18, 2015

In Brief

A Phase 2 clinical trial evaluating alkaline water, distilled water, and 1 other intervention for Radiation Toxicity and 7 related conditions. Completed, enrolled 45 participants across 1 site.

Detailed Summary

This phase II trial is studying how well alkaline water works in reducing skin toxicity in women with breast cancer undergoing radiation therapy. Alkaline water may reduce radiation therapy-related skin toxicity in patients with breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRadiation Toxicity, Recurrent Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 8, 2011
Enrollment StartMay 1, 2010
Primary CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 14.6 years ago

Interventions

alkaline waterdietary

Patients drink 8 ounces of alkaline water within 30 minutes immediately prior to and after undergoing radiation therapy.

distilled waterdietary

Patients also drink 8 ounces of distilled water within 30 minutes immediately prior to and after undergoing radiation therapy.

external beam radiation therapy (EBRT)radiation

Patients undergo external beam radiation therapy QD, 5 days a week for 6 weeks.